AR075846A1 - Sistema de administracion de farmaco de lactona macrociclica.uso. metodo de tratamiento - Google Patents
Sistema de administracion de farmaco de lactona macrociclica.uso. metodo de tratamientoInfo
- Publication number
- AR075846A1 AR075846A1 ARP100100817A ARP100100817A AR075846A1 AR 075846 A1 AR075846 A1 AR 075846A1 AR P100100817 A ARP100100817 A AR P100100817A AR P100100817 A ARP100100817 A AR P100100817A AR 075846 A1 AR075846 A1 AR 075846A1
- Authority
- AR
- Argentina
- Prior art keywords
- drug delivery
- delivery system
- macrocyclic lactone
- administration system
- macrociclica
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Reivindicacion 1: Un sistema de administracion de fármaco para la liberacion controlada de una lactona macrocíclica como ingrediente activo, que comprende un deposito no poroso solido de un copolímero de polietileno acetato de vinilo farmacéuticamente aceptable, cargado con la lactona macrocíclica y un recubrimiento no poroso que cubre el deposito, el recubrimiento comprende un copolímero de polietileno acetato de vinilo, donde la lactona macrocíclica es liberada sustancialmente por difusion a través del recubrimiento del sistema de administracion de fármaco. Reivindicacion 7: Un sistema de administracion de fármaco de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizado porque la lactona macrocíclica se selecciona entre el grupo que comprende ivermectina, moxidectina, selamectina, doramectina, abamectina y mezclas de ellos. Reivindicacion 8: Un sistema de administracion de fármaco de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizado porque el deposito comprende un agente de radiocontraste, preferentemente, sulfato de bario. Reivindicacion 10: Un sistema de administracion de fármaco de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizado porque el sistema de administracion se presenta en forma de implante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16094209P | 2009-03-17 | 2009-03-17 | |
EP09155383 | 2009-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR075846A1 true AR075846A1 (es) | 2011-04-27 |
Family
ID=40941503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100100817A AR075846A1 (es) | 2009-03-17 | 2010-03-16 | Sistema de administracion de farmaco de lactona macrociclica.uso. metodo de tratamiento |
Country Status (11)
Country | Link |
---|---|
US (1) | US9345686B2 (es) |
EP (1) | EP2408432A1 (es) |
JP (1) | JP2012520847A (es) |
KR (1) | KR20120006987A (es) |
CN (1) | CN102355891A (es) |
AR (1) | AR075846A1 (es) |
AU (1) | AU2010224918A1 (es) |
BR (1) | BRPI1009345A2 (es) |
CA (1) | CA2755753A1 (es) |
MX (1) | MX2011009678A (es) |
WO (1) | WO2010106046A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3682887A1 (en) * | 2010-07-30 | 2020-07-22 | Ceva Sante Animale | Compositions comprising ivermectin for treating heartworm infestation |
CN103153313A (zh) * | 2010-07-30 | 2013-06-12 | 法国诗华动物保健公司 | 用于防治恶丝虫侵袭的组合物 |
CL2014000989A1 (es) * | 2014-04-17 | 2014-10-17 | Univ Santiago Chile | Dispositivo subdermal de liberacion prolongada y lenta para prevencion, tratamiento y monitoreo de parasitos, que comprende al menos una lactona macrociclica tal como ivermectina y/o dormectina, opcionalmente nanoparticulas o microparticulas de zeolita, una matriz polimerica y medios de monitoreo, dentro de un circuito integrado. |
US10406336B2 (en) * | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
WO2018064556A1 (en) | 2016-09-29 | 2018-04-05 | Gesea Biosciences Inc. | Bioerodible implant for long-term drug delivery and associated methods of manufacture and use |
WO2019226516A1 (en) * | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
CN111989068A (zh) | 2018-05-24 | 2020-11-24 | 塞拉尼斯伊娃高性能聚合物公司 | 用于持续释放大分子药物化合物的可植入器件 |
MX2020014160A (es) * | 2018-06-25 | 2021-03-09 | Titan Pharmaceuticals Inc | Implantes para liberacion de sustancias farmaceuticas lipofilicas o anfifilicas. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3950360A (en) | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
US3984564A (en) | 1972-06-08 | 1976-10-05 | Sankyo Company Limited | Antibiotic substances B-41, their production and their use as insecticides and acaricides |
US4144317A (en) | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
ES8800986A1 (es) | 1985-07-27 | 1987-12-01 | Pfizer | Un procedimiento para la produccion de un nuevo derivado de avermectina |
US4916154A (en) | 1986-09-12 | 1990-04-10 | American Cyanamid Company | 23-Imino derivatives of LL-F28249 compounds |
IL98599A (en) | 1990-06-28 | 1995-06-29 | Merck & Co Inc | Stable salts of "4-deoxy-" 4-epi-methylamino abramectin and insecticides containing them |
US5399717A (en) | 1993-09-29 | 1995-03-21 | Merck & Co., Inc. | Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1 |
AUPR602501A0 (en) | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
AUPR610501A0 (en) * | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
AUPR951501A0 (en) * | 2001-12-14 | 2002-01-24 | Smart Drug Systems Inc | Modified sustained release pharmaceutical system |
ES2327247T3 (es) * | 2004-03-24 | 2009-10-27 | N.V. Organon | Sistema de administracion de farmacos basado en copolimeros de polietileno y acetato de vinilo. |
BRPI0504244A (pt) * | 2005-09-29 | 2007-09-25 | Clarion Biociencias Ltda | implantes subdérmicos de etilenovilacetato (eva) e polydimethylsiloxane (silicone) que consiste na utilização de eva ou silicone para uso como matriz plástica endectocida, associado ou não a um ectoparasiticida e/ou igr, para confecções de implantes subdérmicos para utilização em bovinos, cães e gatos e respectivo método de produção |
-
2010
- 2010-03-16 AU AU2010224918A patent/AU2010224918A1/en not_active Abandoned
- 2010-03-16 BR BRPI1009345A patent/BRPI1009345A2/pt not_active IP Right Cessation
- 2010-03-16 WO PCT/EP2010/053339 patent/WO2010106046A1/en active Application Filing
- 2010-03-16 EP EP10709491A patent/EP2408432A1/en not_active Withdrawn
- 2010-03-16 AR ARP100100817A patent/AR075846A1/es unknown
- 2010-03-16 JP JP2012500218A patent/JP2012520847A/ja not_active Withdrawn
- 2010-03-16 CA CA2755753A patent/CA2755753A1/en not_active Abandoned
- 2010-03-16 CN CN2010800125011A patent/CN102355891A/zh active Pending
- 2010-03-16 MX MX2011009678A patent/MX2011009678A/es not_active Application Discontinuation
- 2010-03-16 US US13/256,264 patent/US9345686B2/en not_active Expired - Fee Related
- 2010-03-16 KR KR1020117022800A patent/KR20120006987A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20120052108A1 (en) | 2012-03-01 |
EP2408432A1 (en) | 2012-01-25 |
BRPI1009345A2 (pt) | 2016-03-08 |
US9345686B2 (en) | 2016-05-24 |
CA2755753A1 (en) | 2010-09-23 |
MX2011009678A (es) | 2011-09-30 |
CN102355891A (zh) | 2012-02-15 |
AU2010224918A1 (en) | 2011-10-06 |
WO2010106046A1 (en) | 2010-09-23 |
JP2012520847A (ja) | 2012-09-10 |
KR20120006987A (ko) | 2012-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR075846A1 (es) | Sistema de administracion de farmaco de lactona macrociclica.uso. metodo de tratamiento | |
US20170246302A1 (en) | Polymer coating compositions and coated products | |
WO2008098927A3 (en) | Degradable reservoir implants | |
DOP2010000253A (es) | Sistema de administracion de drogas con efecto estabilizante | |
WO2007038246A3 (en) | Solid polymer delivery compositions and methods for use thereof | |
PE20100057A1 (es) | Sistema de suministro intrauterino para la liberacion controlada de progestageno | |
US10729820B2 (en) | Methods and processes for application of drug delivery polymeric coatings | |
PE20091184A1 (es) | Formas de dosificacion farmaceutica | |
PE20160680A1 (es) | Sistema de administracion farmacologica | |
NZ603579A (en) | Controlled release formulations | |
JP2013507204A (ja) | カテーテルバルーンをコーティングするための組成物の使用およびコーティングされたカテーテルバルーン | |
JP2016532505A5 (es) | ||
JP2004523275A5 (es) | ||
WO2008008389A3 (en) | Implantable sustained drug delivery device for releasing active agents to the osteomeatal complex | |
SG11201907260PA (en) | Physiologically active substance carrier | |
WO2009128944A3 (en) | Coating systems for the controlled delivery of hydrophilic bioactive agents | |
HRP20221252T1 (hr) | Sustavi isporuke lijeka i postupci za liječenje raka mokraćnog mjehura s gemcitabinom | |
WO2008021124A3 (en) | Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel | |
JP2011507838A5 (es) | ||
WO2007118131A3 (en) | Methods and devices for reducing tissue damage after ischemic injury | |
WO2011089624A3 (en) | Insertable medical devices with porous bed for delivering nano-carriers to target site and preparing methods thereof | |
ES2744848T3 (es) | Dispositivo médico de liberación de inhibidor de mTOR | |
JP2019529433A5 (es) | ||
ES2950392T3 (es) | Espumas de elución de fármacos y producción de las mismas | |
RU2022100624A (ru) | Способ лечения рака уротелия нижних путей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |